Immunotec Announces Recent Claim

Immunotec Inc. (TSX VENTURE:IMM), a Canadian based company and a leader in the
wellness industry (the "Company"), today announced that it has recently received
a demand letter from Mr. Robert M. Henry, former Chairman of the Board of
Directors and CEO of the Company, claiming the amount of approximately $1.1
million in relation to the termination of his employment and other claims on
Friday, May 10, 2013. 


The Company has retained the services of an experienced labour and employment
lawyer to assist and represent it in this matter. While the Company will attempt
to reach an amicable and reasonable settlement with Mr. Henry, should this not
be possible, it will vigorously defend its interests and those of its
shareholders.


About Immunotec Inc. 

Immunotec is a world class business opportunity supported by unique
scientifically proven products that improve wellness. Headquartered with
manufacturing facilities near Montreal, Canada, the Company also has
distribution capacities to support its commercial activities in Canada and
internationally to the United States, Europe, Mexico and the Caribbean. 


The Company files its consolidated financial statements, its management and
discussion analysis report, its press releases and such other required documents
on the SEDAR database at www.sedar.com and on the Company's website at
www.immunotec.com. The common shares of the Company are listed on the TSX
Venture Exchange under the ticker symbol IMM. 


CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain statements contained in
this news release are forward-looking and are subject to numerous risks and
uncertainties, known and unknown. For information identifying known risks and
uncertainties and other important factors that could cause actual results to
differ materially from those anticipated in the forward-looking statements,
please refer to the heading Risks and Uncertainties in Immunotec's most recent
Management's Discussion and Analysis, which can be found at www.sedar.com.
Consequently, actual results may differ materially from the anticipated results
expressed in these forward-looking statements.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Patrick Montpetit CPA;CA CF,
Vice president and Chief Financial Officer
Immunotec Inc.
[phone]